05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
Obligations under the Occupational Safety and Health Act - The Occupational Safety and Health Act ...
Read More >
Key Takeaways - - On July 31, 2020, the U.S. Treasury Department, as chair of the Committee on Fore...
Read More >
We’ve previously written about how appraisal rights are a factor considered by deal-makers during t...
Read More >
The Fourth Circuit’s recent decision in Evangeline Parker v. Reema Consulting Services, Incorporate...
Read More >
In Chief Counsel Memorandum 20200801F, released on February 21, 2020, the IRS established its positi...
Read More >
Complex construction projects have many moving parts and numerous stakeholders. Each project often ...
Read More >